Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03826992
Title Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Children's Hospital Medical Center, Cincinnati
Indications

acute leukemia

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

CPX-351 + Venetoclax

Age Groups: child | adult
Covered Countries USA

Additional content available in CKB BOOST